miR-223 plays a critical role in the progression of nonalcoholic steatohepatitis (NASH) to HCC by targeting Taz and the inflammatory gene Cxcl10 in mouse hepatocytes [72]. This evidence concerns the gene CXCL10 and metabolic dysfunction-associated steatohepatitis.